Cardiotoxic potential and CNS effects of first-generation antihistamines

Author： Taglialatela M.M. Timmerman H.H. Annunziato L.L.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.2, 2000-02, pp. : 52-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis

By Patrick W. Sullivan

PharmacoEconomics, Vol. 22, Iss. 14, 2004-01 ,pp. : 929-942

Adis International

Access to resources Recommend Favorite

Assessment of the First and Second Generation Antihistamines Brain Penetration and Role of P-Glycoprotein

By Obradovic Tanja Dobson Glenn Shingaki Tomotaka Kungu Thomas Hidalgo Ismael

Pharmaceutical Research, Vol. 24, Iss. 2, 2007-02 ,pp. : 318-327

Springer Publishing Company

Access to resources Recommend Favorite

Cardiotoxicity of Second-Generation Antihistamines

By Roberts D.J.

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 1033-1034

Adis International

Access to resources Recommend Favorite

Cardiotoxic effects of anthracycline–taxane combinations

By Perotti Antonella Cresta Sara Grasselli Giacomo Capri Giuseppe Minotti Giorgio Gianni Luca

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 59-71

Informa Healthcare

Access to resources Recommend Favorite

First-Generation Drug-Eluting Stents … and Beyond

By Wijns William

Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. : 771-773

Adis International

Access to resources Recommend Favorite